Bar-Sela G - Search Results

1

Deep learning-based image analysis predicts PD-L1 status from H&E-stained histopathology images in breast cancer.

Shamai G, Livne A, Polónia A, Sabo E, Cretu A, Bar-Sela G, Kimmel R. Shamai G, et al. Nat Commun. 2022 Nov 8;13(1):6753. doi: 10.1038/s41467-022-34275-9. Nat Commun. 2022. PMID: 36347854 Free PMC article.

2

Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults.

Bar-Sela G, Ben Arush MW, Sabo E, Kuten A, Minkov I, Ben-Izhak O. Bar-Sela G, et al. Pediatr Blood Cancer. 2005 Sep;45(3):291-7. doi: 10.1002/pbc.20264. Pediatr Blood Cancer. 2005. PMID: 15558705

3

The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma.

Uryvaev A, Passhak M, Hershkovits D, Sabo E, Bar-Sela G. Uryvaev A, et al. Med Oncol. 2018 Jan 31;35(3):25. doi: 10.1007/s12032-018-1080-0. Med Oncol. 2018. PMID: 29388007

4

ARTS mediates apoptosis and regeneration of the intestinal stem cell niche.

Koren E, Yosefzon Y, Ankawa R, Soteriou D, Jacob A, Nevelsky A, Ben-Yosef R, Bar-Sela G, Fuchs Y. Koren E, et al. Nat Commun. 2018 Nov 2;9(1):4582. doi: 10.1038/s41467-018-06941-4. Nat Commun. 2018. PMID: 30389919 Free PMC article.

5

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5^-/- mice.

Li Y, Tinoco R, Elmén L, Segota I, Xian Y, Fujita Y, Sahu A, Zarecki R, Marie K, Feng Y, Khateb A, Frederick DT, Ashkenazi SK, Kim H, Perez EG, Day CP, Segura Muñoz RS, Schmaltz R, Yooseph S, Tam MA, Zhang T, Avitan-Hersh E, Tzur L, Roizman S, Boyango I, Bar-Sela G, Orian A, Kaufman RJ, Bosenberg M, Goding CR, Baaten B, Levesque MP, Dummer R, Brown K, Merlino G, Ruppin E, Flaherty K, Ramer-Tait A, Long T, Peterson SN, Bradley LM, Ronai ZA. Li Y, et al. Nat Commun. 2019 Apr 2;10(1):1492. doi: 10.1038/s41467-019-09525-y. Nat Commun. 2019. PMID: 30940817 Free PMC article.

6

Biopsy of breast cancer metastases: patient characteristics and survival.

Shachar SS, Mashiach T, Fried G, Drumea K, Shafran N, Muss HB, Bar-Sela G. Shachar SS, et al. BMC Cancer. 2017 Jan 4;17(1):7. doi: 10.1186/s12885-016-3014-6. BMC Cancer. 2017. PMID: 28052766 Free PMC article.

7

Reply to D.B. Scarpelli et al.

Turgeman I, Bar-Sela G. Turgeman I, et al. JCO Oncol Pract. 2021 Oct;17(10):645-646. doi: 10.1200/OP.21.00487. Epub 2021 Aug 26. JCO Oncol Pract. 2021. PMID: 34436953 No abstract available.

8

Physicians' Considerations for Repeat Biopsy in Patients With Recurrent Metastatic Breast Cancer.

Shachar SS, Fried G, Drumea K, Shafran N, Bar-Sela G. Shachar SS, et al. Clin Breast Cancer. 2016 Jun;16(3):e43-8. doi: 10.1016/j.clbc.2015.10.006. Epub 2015 Nov 10. Clin Breast Cancer. 2016. PMID: 26642811

9

The prognostic significance of heparanase expression in metastatic melanoma.

Vornicova O, Boyango I, Feld S, Naroditsky I, Kazarin O, Zohar Y, Tiram Y, Ilan N, Ben-Izhak O, Vlodavsky I, Bar-Sela G. Vornicova O, et al. Oncotarget. 2016 Nov 15;7(46):74678-74685. doi: 10.18632/oncotarget.12492. Oncotarget. 2016. PMID: 27732945 Free PMC article.

10

Breast cancer in young women aged 35 and under: Patterns of care and outcome.

Passhak M, Shachar SS, Bar-Sela G, Fried G. Passhak M, et al. Breast J. 2018 May;24(3):441-443. doi: 10.1111/tbj.12966. Epub 2017 Nov 15. Breast J. 2018. PMID: 29139588 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page